1 Product identity
Ingredient risk
Contains restricted ingredients
Ocuvite Eye+Multi
BrandBausch & Lomb→Other Combinations Tablet or Pill 57 ingredients 1 banned 6 caution DSLD #17096Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-01-25
2 Ingredients (57)
IngredientGroupSafety
Vitamin B5Vitamin B5—
ZeaxanthinZeaxanthin—
LycopeneLycopene—
Microcrystalline CelluloseCellulose—
Hydroxypropyl CelluloseHypromellose—
CrospovidoneCrospovidone—
Polyvinyl AlcoholPolyvinyl alcohol—
Polyethylene GlycolPolyethylene glycol—
CaramelColor—
CarmineColor—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
Contains an ingredient banned in ≥1 country
Titanium Dioxide — France banned TiO₂ in food from January 2020, first EU country.
Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
Thiamin — Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patie…
Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…
Vitamin B12 — Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective p…
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
Zinc — Chronic zinc >40 mg/day without copper causes copper deficiency: anemia, neutropenia, myeloneuropathy [1].
3 Safety cross-reference
Vitamin A — Conditionally Safe
Teratogenic at high doses
Hepatotoxic with chronic excess
Vitamin C — Generally Safe
GI distress at high doses
Kidney stones risk >1g/day
Vitamin D — Use with Caution
Hypercalcemia at >10,000 IU/day
Vascular calcification risk
Vitamin E — Conditionally Safe
Increased bleeding risk
All-cause mortality at >400 IU/day
Vitamin K — Conditionally Safe
Critical interaction with warfarin
Thiamin — Use with Caution
Very low toxicity
Riboflavin — Generally Safe
Harmless yellow urine
Niacin — Conditionally Safe
Flushing at >50 mg
Hepatotoxicity at high doses
Vitamin B6 — Use with Caution
Folate — Conditionally Safe
May mask B12 deficiency
Colorectal cancer risk debated
Vitamin B12 — Use with Caution
Biotin — Generally Safe
Interferes with troponin and thyroid lab assays
Calcium — Conditionally Safe
Cardiovascular risk debated >1,000 mg/day
Kidney stones
Phosphorus — Generally Safe
Excess impairs calcium absorption
Iodine — Conditionally Safe
Thyroid dysfunction at excess
Kelp: variable content
Magnesium — Use with Caution
Diarrhea (especially oxide)
Accumulates in renal impairment
Zinc — Use with Caution
Copper deficiency at >40 mg/day
Nausea, metallic taste
Selenium — Conditionally Safe
Selenosis >400 mcg
Diabetes risk at high doses
Copper — Conditionally Safe
Hepatotoxicity at high doses
Manganese — Conditionally Safe
Neurotoxicity with chronic excess
Chromium — Conditionally Safe
Hypoglycemia with diabetes meds
Rare renal/hepatic toxicity
Molybdenum — Generally Safe
Very low toxicity
Lutein — Generally Safe
Harmless skin yellowing at very high doses
Silicon — Generally Safe
Very low toxicity
Sodium — Conditionally Safe
Hypertension
Fluid retention
Titanium Dioxide — Banned in ≥1 country
EFSA: can no longer be considered safe as food additive (2021)
Genotoxicity concern (nanoparticles)
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID17096
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-01-25
6 More from Bausch & Lomb
View Bausch & Lomb Safety Scorecard → 9 products
Ocuvite Adult 50+Ocuvite Eye Health FormulaOcuvite Eye Health FormulaOcuvite Lutein & ZeaxanthinOcuvite With LuteinPreserVision AREDS Soft Gels7 Cite this page
Vancouver
Pkhakadze G. Ocuvite Eye+Multi — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Nov 17]. Available from: https://supplement.ge/products/dsld-17096/
CC BY 4.0. Product data from NIH DSLD; safety analysis by supplement.ge.
GP
Analyzed by supplement.ge
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by supplement.ge. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG